Autor: Wolfgang Hiddemann

Wolfgang Hiddemann, MD, Ph D, is Professor of Medicine and Director of the Department of Internal Medicine III at the University of Munich, Germany. Dr Hiddemann is best known for his research on the pathogenesis of acute leukemias, and clinical trials in acute leukemias and malignant lymphomas. He is head of the German AML Cooperative Group (AMLCG), the German Low Grade Lymphoma Study Group (GLSG), and founding chairman of the European Mantle-Cell-Lymphoma Network. He is an active member of the editorial boards of several international journals and has been a member of the Steering Committees for the German Society of Hematology and Oncology and the German Cancer Aid. Dr Hiddemann has published nearly 600 scientific articles addressing various aspects of research in malignant lymphomas and acute leukemias. He has been awarded honorary memberships of the Hungarian Society of Hematology and Oncology and of the South African Society for Hematology. He also received the Honorary Medal ofthe Polish Society for Internal Medicine. In 2003, he was awarded the Charles Burpbacher Lectureship in Zürich, Switzerland, and in the same year the Emil Frei Leukemia Lectureship, Harvard University, Boston. He has also received the Jacqueline Seroussi Foundation Scientific Award.